← FDA DRUG APPROVALS

FDA ANDA · ANDA075170

BUTORPHANOL TARTRATE PRESERVATIVE FREE

Sponsor: HOSPIRA

APPLICATION
ANDA075170
TYPE
ANDA
ORIGINAL APPROVAL
1998-09-28
LATEST ACTION
2002-12-20
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

BUTORPHANOL TARTRATE PRESERVATIVE FREEDiscontinued
BUTORPHANOL TARTRATE 1MG/ML · INJECTABLE · INJECTION
BUTORPHANOL TARTRATE PRESERVATIVE FREEDiscontinued
BUTORPHANOL TARTRATE 2MG/ML · INJECTABLE · INJECTION

Approval history

2002-12-20Manufacturing (CMC) · Supplement 9AP
2002-05-03Manufacturing (CMC) · Supplement 8AP
2002-05-03Manufacturing (CMC) · Supplement 7AP
2001-06-28Manufacturing (CMC) · Supplement 6AP
2001-06-13Manufacturing (CMC) · Supplement 4AP
2000-08-18Manufacturing (CMC) · Supplement 2AP
1999-12-01Labeling · Supplement 3AP
1999-07-22Manufacturing (CMC) · Supplement 1AP
1998-09-28OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →